Peter A. Altman
CEO, President & DirectorDr. Peter A. Altman, Ph.D. has been Chief Executive Officer and President of BioCardia, Inc. since 2002. Dr. Altman served as an acting Chief Executive Officer of Lumen Therapeutics from 2004 to 2005. He served as Founding Chief Executive Officer of Expression Diagnostics, Inc., from 2000 to 2003. Dr. Altman served as founding President and Chief Executive Officer for CareDx, Inc. from 1999 to 2003. He is a Director of Oncocyclist Biotech since 2018. He was also an inventor of the technology that is being developed by medical device start up Sinus Rhythm Technologies, Inc. and has raised more than $20 M for California based life sciences companies, from investors including Kleiner Perkins Caufield and Byers and Texas Pacific Group Ventures. Previously, he was with Ventritex (acquired by St Jude Medical) developing AICD technology. He has an experience in life science research and product development, is named inventor in 50 US patents and has authored 40 scientific publications. He served as founding Chief Executive Officer from 1999 to 2003 and Director of CareDx Inc. from 1999 to 2014. He serves as a Director of BioCardia, Inc. since 2002. He served as Director of Lumen Therapeutics from 2004 to 2005. Dr. Altman holds PhD in Bioengineering and Pharmaceutical Chemistry in year 2003 from the University of California San Francisco and University of California Berkeley, his Management of Technology certificate from the Haas School of Business, University of California Berkeley and both his Master of Science in year 1990 and Bachelors of Science degrees in Mechanical Engineering in year 1988 from the Columbia University School of Engineering and Applied Sciences. Dr. Altman has been elected Fellow of the American Heart Association.
Positions
- Company NameBioCardia, Inc.Stock CodeBCDAPositionCEO, President & Director
